Immediate Impact
1 by Nobel laureates 12 from Science/Nature 57 standout
Citing Papers
Mitochondrial dysfunction: mechanisms and advances in therapy
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Silvana Mourón being referenced
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
2021
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Silvana Mourón | 234 | 351 | 848 | 43 | 1.3k | |
| Cyrille Cuenin | 255 | 200 | 1279 | 47 | 1.6k | |
| J Frei | 234 | 296 | 515 | 45 | 1.3k | |
| Aaron E. Freeman | 243 | 279 | 555 | 36 | 1.3k | |
| David Baunoch | 404 | 547 | 656 | 49 | 1.6k | |
| Joseph A. Rafferty | 316 | 419 | 1087 | 47 | 1.5k | |
| Maria Grazia Sacco | 517 | 147 | 585 | 49 | 1.7k | |
| Rolf I. Carlson | 202 | 220 | 590 | 39 | 1.3k | |
| Luís Lombardía | 245 | 402 | 989 | 31 | 1.6k | |
| Jianghuai Liu | 284 | 196 | 781 | 43 | 1.4k | |
| Éric Tabone | 364 | 191 | 705 | 57 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...